WEX Inc. (WEX)

NYSEFinancialsSoftware - InfrastructureSnapshot 2026-10-23

$197.46-0.34%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge WEX Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.6%

+10% or more+5%0%−5%−10% or less

21.23 → 21.35 EPS · FY ending Dec 31, 2027 · 11 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 11 to 11; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	717.49M
EPS	—	4.994
Annual ending 2026-12-31
Revenue	—	2.9B
EPS	—	20.223
Annual ending 2027-12-31
Revenue	—	2.94B
EPS	—	21.352

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
EPS near $19.25 in FY26	A primary condition in WEX Inc.'s published investment case. The stated target is ~19.25 USD per share.	Intact	EPS falls below $18.95 in FY26	Diluted EPS: $3.11 per share FY2026-Q2; GAAP. Published target: ~19.25 USD per share. Target period is not explicitly aligned with this observation. Source published Jul 23, 20263.11 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 5d9b9f69-58a6-4678-a5fc-e4783f6c9fc2. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Progress on amplifying core and expanding reach	Management is focused on expanding the core business and innovation.	Intact	Progress score falls below 70%	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Revenue grew from $672.9 million in 2025-Q4 to $753.5 million in 2026-Q2, and net income increased from $84.3 million to $108.5 million. Management consistently emphasizes growth through core amplification, market expansion, and innovation including AI, and financials show delivering trajectory. Delivery assessment Oct 20, 2026
Revenue growth at or above 5% annually	A primary condition in WEX Inc.'s published investment case. The stated target is >=5% YoY.	Under Pressure	YoY revenue growth falls below 5% in FY26	Revenue growth: 14.24% FY2026-Q2; GAAP. Published target: >=5% YoY. Target period is not explicitly aligned with this observation. Source published Jul 23, 202614.235901 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 5d9b9f69-58a6-4678-a5fc-e4783f6c9fc2. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Revenue grew from $672.9 million in 2025-Q4 to $753.5 million in 2026-Q2, and net income increased from $84.3 million to $108.5 million. Management consistently emphasizes growth through core amplification, market expansion, and innovation including AI, and financials show delivering trajectory. Delivery assessment Oct 20, 2026
Execute $1 billion share repurchase program	The company is buying back up to $1 billion in stock, which supports the share price.	Intact	Buyback program is cancelled or materially delayed	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated or evidenced in 2 quarters including a May 2026 announcement and 2026-Q2 results. The Board authorized up to $1.0 billion in share repurchases with no expiration. Approximately $93 million was repurchased from May through July 20, 2026, showing active execution of the program and delivering trajectory. Delivery assessment Oct 20, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$21.35

$20.43 → $21.35 · observed estimates

FY2027 revenue$2.94B

$2.93B → $2.94B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$20.43	$2,928,396,610	14 / 13
2026-07-25	$20.91	$2,927,677,180	14 / 14
2026-07-26	$20.91	$2,927,677,180	14 / 14
2026-07-27	$21.01	$2,928,311,720	10 / 11
2026-07-28	$21.01	$2,928,311,720	10 / 11
2026-07-29	$21.13	$2,930,111,720	10 / 12
2026-07-30	$21.13	$2,930,111,720	10 / 12
2026-07-31	$21.13	$2,930,111,720	10 / 12
2026-08-01	$21.13	$2,930,111,720	10 / 12
2026-08-02	$21.09	$2,930,073,450	14 / 14
2026-08-03	$21.09	$2,930,073,450	14 / 14
2026-08-04	$21.09	$2,930,073,450	14 / 14
2026-08-05	$21.13	$2,930,111,720	10 / 12
2026-08-06	$21.09	$2,930,073,450	14 / 14
2026-08-08	$21.13	$2,930,111,720	10 / 12
2026-08-09	$21.13	$2,930,111,720	10 / 12
2026-08-10	$21.09	$2,930,073,450	14 / 14
2026-08-12	$21.13	$2,930,111,720	10 / 12
2026-08-13	$21.13	$2,930,111,720	10 / 12
2026-08-14	$21.13	$2,930,111,720	10 / 12
2026-08-15	$21.13	$2,930,111,720	10 / 12
2026-08-16	$21.13	$2,930,111,720	10 / 12
2026-08-17	$21.13	$2,930,111,720	10 / 12
2026-08-18	$21.13	$2,930,111,720	10 / 12
2026-08-19	$21.13	$2,930,111,720	10 / 12
2026-08-20	$21.13	$2,930,111,720	10 / 12
2026-08-21	$21.13	$2,930,111,720	10 / 12
2026-08-22	$21.13	$2,930,111,720	10 / 12
2026-08-23	$21.13	$2,930,111,720	10 / 12
2026-08-24	$21.13	$2,930,111,720	10 / 12
2026-08-25	$21.13	$2,930,111,720	10 / 12
2026-08-26	$21.23	$2,930,111,720	10 / 12
2026-08-27	$21.23	$2,930,111,720	10 / 12
2026-08-28	$21.23	$2,930,111,720	10 / 12
2026-08-29	$21.23	$2,930,111,720	10 / 12
2026-08-30	$21.23	$2,930,111,720	10 / 12
2026-08-31	$21.23	$2,930,111,720	10 / 12
2026-09-01	$21.23	$2,930,111,720	10 / 12
2026-09-02	$21.23	$2,930,111,720	10 / 12
2026-09-03	$21.23	$2,930,111,720	10 / 12
2026-09-04	$21.23	$2,930,111,720	10 / 12
2026-09-05	$21.23	$2,930,111,720	10 / 12
2026-09-06	$21.23	$2,930,111,720	10 / 12
2026-09-07	$21.23	$2,930,111,720	10 / 12
2026-09-08	$21.23	$2,930,111,720	10 / 12
2026-09-09	$21.23	$2,930,111,720	10 / 12
2026-09-10	$21.23	$2,930,111,720	10 / 12
2026-09-11	$21.23	$2,930,111,720	10 / 12
2026-09-12	$21.23	$2,931,237,605	11 / 12
2026-09-13	$21.23	$2,931,237,605	11 / 12
2026-09-14	$21.23	$2,931,237,605	11 / 12
2026-09-15	$21.23	$2,931,237,605	11 / 12
2026-09-16	$21.23	$2,931,237,605	11 / 13
2026-09-17	$21.23	$2,931,237,605	11 / 13
2026-09-18	$21.23	$2,931,237,605	11 / 13
2026-09-19	$21.23	$2,931,237,605	11 / 13
2026-09-20	$21.23	$2,931,237,605	11 / 13
2026-09-21	$21.23	$2,931,237,605	11 / 13
2026-09-22	$21.23	$2,931,237,605	11 / 13
2026-09-23	$21.23	$2,931,237,605	11 / 13
2026-09-24	$21.23	$2,931,237,605	11 / 13
2026-09-25	$21.24	$2,932,477,605	11 / 13
2026-09-26	$21.24	$2,932,477,605	11 / 13
2026-09-27	$21.24	$2,932,477,605	11 / 13
2026-09-28	$21.24	$2,932,477,605	11 / 13
2026-09-29	$21.24	$2,932,477,605	11 / 13
2026-09-30	$21.24	$2,932,477,605	11 / 13
2026-10-01	$21.24	$2,932,477,605	11 / 13
2026-10-02	$21.24	$2,932,477,605	11 / 13
2026-10-03	$21.24	$2,932,477,605	11 / 13
2026-10-04	$21.24	$2,932,477,605	11 / 13
2026-10-05	$21.24	$2,932,477,605	11 / 13
2026-10-06	$21.24	$2,932,477,605	11 / 13
2026-10-07	$21.29	$2,932,477,605	11 / 13
2026-10-08	$21.29	$2,932,477,605	11 / 13
2026-10-09	$21.34	$2,939,837,605	11 / 13
2026-10-10	$21.34	$2,939,837,605	11 / 13
2026-10-11	$21.34	$2,939,837,605	11 / 13
2026-10-12	$21.34	$2,939,837,605	11 / 13
2026-10-13	$21.34	$2,939,837,605	11 / 13
2026-10-14	$21.34	$2,939,811,859	11 / 13
2026-10-15	$21.34	$2,939,811,859	11 / 13
2026-10-16	$21.34	$2,939,811,859	11 / 13
2026-10-17	$21.34	$2,939,811,859	11 / 13
2026-10-18	$21.36	$2,943,559,566	11 / 13
2026-10-19	$21.36	$2,943,559,566	11 / 13
2026-10-20	$21.36	$2,943,559,566	11 / 13
2026-10-21	$21.36	$2,943,559,566	11 / 13
2026-10-22	$21.35	$2,941,559,566	11 / 13
2026-10-23	$21.35	$2,941,559,566	11 / 13
2026-10-24	$21.35	$2,941,559,566	11 / 13

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	5	9
2026-06-01	5	9
2026-07-01	5	9
2026-08-01	5	9
2026-09-01	5	10
2026-10-01	5	10

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 5 Buy / Strong Buy · 10 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

EPS near $19.25 in FY26Diluted EPS: $3.11 per share
Progress on amplifying core and expanding reachDirect metric needs a verified mapping
Revenue growth at or above 5% annuallyPublished status: Under Pressure
Execute $1 billion share repurchase programDirect metric needs a verified mapping

Next proof point

Oct 28, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.4%Typical daily move · historical

Downside history

-31.4%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

WEX Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

WEX is a growth-oriented financial services business, not a turnaround thesis. Its long-term thesis is intact, with management priorities on core growth, wider reach, and innovation showing progress, though recent company quality has weakened.

What's priced into WEX Inc.

The valuation evidence points in two directions: WEX is described as cheap versus peers, yet the overall value assessment is expensive. The expectations gap is small, and the pricing assessment says current expectations are justified rather than marked by unusually concentrated fragility.

What the fundamentals likely do

Near term, revenue and net income rose between the final quarter of 2025 and the second quarter of 2026, and management’s growth priorities remain on track. However, earnings quality is fragile, the sector backdrop is a headwind, and the company’s quality score recently fell; the stated chance of a near-term miss is low, but recent misses remain a watch point.

What WEX Inc. hinges on

The multi-year view depends on management sustaining growth without reversing its recently raised guidance, since a reversal could damage confidence as well as lower expectations. Near-term sector support also depends on interest rates and results from sector peers: rate cuts are a stated risk, while continued peer earnings strength and higher guidance could support sector momentum.